MedCity News

JULY 13, 2023

FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.

FDA 246

FDA Prescription Healthcare Healthcare 246

MedCity News

JULY 11, 2023

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

FDA 189

FDA Prescription Biopharma Medical 189

pharmaphorum

DECEMBER 18, 2022

The clerical overhead of enrolment forms navigated over fax and phone calls fails to deliver on the promise, resulting in lower-than-expected prescription volumes and lacklustre adoption among prescribers. The post Access solutions: the missing link that prevents biopharma innovation from reaching patients appeared first on.

Biopharma 98

Biopharma Patients Prescription Medical 98

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. The landscape is highly competitive with new prescription medications launching worldwide each year. However, this journey is fraught with challenges as revealed by an in-depth analysis.

Biopharma 59

Biopharma Competition Prescription Marketing 59

pharmaphorum

OCTOBER 24, 2022

A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected. Sumitomo and its subsidiary Sumitovant Biopharma initially offered $22.75 Since then is has also been approved to treat pain associated with endometriosis.

Biopharma 75

Biopharma Marketing Pharma Prescription 75

Clarivate

DECEMBER 14, 2021

The share using physician-only social networks on a monthly basis has increased to 82%, from 58% in 2019, and 37% read pharma email newsletters weekly, versus 30% pre-pandemic (some specialists are more digitally-mature than others – particularly hematology-oncologists, endocrinologists and gastroenterologists).Meanwhile,

Pharma 52

Pharma Healthcare Healthcare Physicians 52

pharmaphorum

DECEMBER 23, 2022

With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly.

Marketing 105

Marketing Sales Medical Patients 105

Pharmaceutical Technology

SEPTEMBER 8, 2022

The speciality drug channel participants, including speciality pharmacies, biopharma companies, and distributors, are transforming their operations with automated and secure data systems and next-generation analytics, which will improve data collection, partner performance and strategy effectiveness. Prescription refill and renewal.

Specialization 45

Specialization Leads Pharma Side effects 45

MedCity News

DECEMBER 22, 2024

As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.

Prescription 299

Prescription Pharmaceutical Biopharma Medical 299

MedCity News

SEPTEMBER 15, 2024

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 295

Medical Healthcare Healthcare Patients 295

MedCity News

JANUARY 25, 2023

As healthcare organizations comply with the federal EPCS mandate, artificial intelligence and digital identity technologies should be utilized to detect, reduce, and remediate drug diversion.

Healthcare 290

Healthcare Healthcare Electronics Prescription 290

pharmaphorum

JUNE 12, 2017

Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans.

Marketing 52

Marketing Engineering Biopharma Prescription 52

Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Biopharma valuations are down, especially for public and earlier-stage companies. What does this mean for pharma marketers? What’s the current situation? Pharmaceutical marketing: Increased utilization of financial support services.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Biopharma valuations are down, especially for public and earlier-stage companies. What does this mean for pharma marketers? What’s the current situation? Pharmaceutical marketing: Increased utilization of financial support services.

Marketing 52

Marketing Pharma Patients Insurance 52

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. The medication referenced in this case study is a prescription medication used, along with diet and exercise, to lower blood sugar in adults with type 2 diabetes. FirstWord PHARMA.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

pharmaphorum

JUNE 24, 2022

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness. ” The post Biogen and Happify partner on digital support for MS patients appeared first on.

Patients 40

Patients Prescription Biopharma Insurance 40

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street.

FDA 52

FDA Prescription Medicine Biopharma 52

Clarivate

FEBRUARY 28, 2023

Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021.

Patients 98

Patients Prescription Pharmacology Healthcare 98

Pharmaceutical Representative Training

JANUARY 29, 2025

While biologics only account for 2% of overall prescriptions, they contribute to 37% of net drug spending [1]. Newer or less prominent manufacturers will struggle the most with these challenges, but there are teams with the experience and tools to overcome these obstacles and get more biosimilars into the pharma market.

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. By end of year, as many as ten adalimumab biosimilars could be on the U.S. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn.

Marketing 97

Marketing Physicians Manufacturing Competition 97

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Patients want to know other patients are involved in what pharma is doing. Learn how pharma is involving them. They want to hear about those patients’ experiences.

Patients 59

Patients Pharma Education Media 59

PM360

SEPTEMBER 15, 2022

People get tired of feeling that they are their sickness; they’re tired of carrying the baggage of being a “patient,” and they want to be seen and treated like the person they are, not the prescription they take. Empathy needs to be a core strategic imperative for pharma brands. This is a tangible human challenge.

Patients 98

Patients Healthcare Healthcare Marketing 98

MedCity News

JUNE 16, 2023

Numerous clinical, regulatory and financial factors are behind this digital shift in pharma. And in the first quarter of this year, the largest Series A ever in digital health ($203M) went into a company accelerating clinical trials and drug development.

Pharma 311

Pharma Food and Drug Administration Recruitment Patients 311

Clarivate

MAY 13, 2024

Many insurers use similar networks for Medicaid and exchange plans, so shifting to an exchange plan is less likely to cause a lapse in coverage or abandonment of prescription drugs or maintenance medications that control chronic conditions.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Clarivate

MARCH 17, 2022

A section of the guidance, FDA Regulations That Govern Research in Pregnant Women , identifies several conditions that must be met in trials supported or conducted by HHS.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

Clarivate

DECEMBER 19, 2022

Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations.

Competition 52

Competition Retail Insurance Marketing 52

World of DTC Marketing

MARCH 16, 2022

The pharma industry’s reputation continues to slip from a pandemic halo-high of 62% in February 2021 to now when fewer than half, just 47%, of people have a favorable view of the industry, according to the Harris Poll’s latest survey. Source: Endpoints News ) Does anyone believe that pharma cares?

Pharma 183

Pharma Government Biopharma Prescription 183

PM360

AUGUST 7, 2024

Christoph Bug Vice President of Global Medical Veeva christoph.bug@veeva.com Functional silos can create tunnel vision and cause misalignment of strategy, objectives, and transparency of interactions with biopharmas and their customers like HCPs. To best align success measures and unify systems (and people) start with the end goal in mind.

Media 52

Media Education Physicians Marketing 52

pharmaphorum

JULY 18, 2022

The separation leaves GSK as a biopharma and vaccines pure-play that chief executive Emma Walmsley has said will deliver £33 billion in annual revenues by 20231, up from £24.5 Last year, GSK rejected a $68 billion bid from Unilever for the consumer health operations, saying the offer “fundamentally undervalued” the business.

Biopharma 124

Biopharma Sales Prescription Pharma 124

Pharmaceutical Technology

NOVEMBER 4, 2022

For example, digital twins of pharmaceutical supply chains can predict bottlenecks and give suggestions for how to respond using prescriptive AI. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

pharmaphorum

SEPTEMBER 26, 2022

Brown isn’t a newbie to the pharma sector, however, having previously held roles at UK drugmaker AstraZeneca and medical device player Smith & Nephew, as well as serving as a non-executive director and audit chair at Roche, before stepping down from that role today. Julie Brown. billion and $1.9 billion, respectively.

Management 52

Management Pharma Biopharma Prescription 52

Clarivate

NOVEMBER 23, 2021

Mike Ward: Oriol, more often than not, the activity around clinical trial management was an activity that was previously outsourced by pharma and biotech companies to clinical research organizations more focused on that topic. Why has Pfizer decided to bring it back in-house? I think we moved away, and Simon would probably agree.

Patients 52

Patients Recruitment Management Healthcare 52

MedCity News

NOVEMBER 12, 2024

Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform. The post What Might the Future of Prescription Drugs Look Like Under Trump? appeared first on MedCity News.

Prescription 290

Prescription Management Biopharma Pharma 290

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. R&D efficiency is more critical than ever.

Biopharma 52

Biopharma Pharma Prescription Marketing 52

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52